Global Pharma Ophthalmic Sales Market Report 2018

眼科用薬剤の世界市場:販売動向2018

◆タイトル:Global Pharma Ophthalmic Sales Market Report 2018
◆商品コード:QYR80710157
◆調査・発行会社:QYResearch
◆発行日:2018年10月
◆ページ数:103
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、世界主要国(日本、アメリカ、中国、ヨーロッパ等)
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥432,000見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD8,000 ⇒換算¥864,000見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

本調査レポートでは、眼科用薬剤の世界市場について調査・分析し、眼科用薬剤のメーカー別販売量、市場シェア分析、種類別販売分析(網膜障害薬、アレルギー性炎症性および感染性薬物、緑内障薬、ドライアイ治療薬、その他)、用途別販売分析(緑内障、ドライアイ症候群、網膜疾患、その他の眼科的適応症)、地域別販売分析(米国、中国、欧州、日本、東南アジア、インド)、価格動向、企業動向、眼科用薬剤産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。

・眼科用薬剤市場概要
・眼科用薬剤のメーカー別販売量・メーカー別シェア
・眼科用薬剤の世界市場:種類別販売量(網膜障害薬、アレルギー性炎症性および感染性薬物、緑内障薬、ドライアイ治療薬、その他)
・眼科用薬剤の世界市場:用途別販売量(緑内障、ドライアイ症候群、網膜疾患、その他の眼科的適応症)
・眼科用薬剤の世界市場:地域別販売量・市場シェア
・眼科用薬剤の米国市場規模
・眼科用薬剤の中国市場規模
・眼科用薬剤の欧州市場規模
・眼科用薬剤の日本市場規模
・眼科用薬剤の東南アジア市場規模
・眼科用薬剤のインド市場規模
・眼科用薬剤のメーカー別分析(企業概要、事業概要、製品概要、収益、価格等)
・眼科用薬剤のコスト分析・価格動向
・眼科用薬剤の産業チェーン(サプライチェーン分析)
・眼科用薬剤のマーケティング戦略・販売チャネル、流通業者
・眼科用薬剤市場への影響要因分析
・眼科用薬剤の世界市場予測
・眼科用薬剤の米国市場予測
・眼科用薬剤の中国市場予測
・眼科用薬剤の欧州市場予測
・眼科用薬剤の日本市場予測
・眼科用薬剤の東南アジア市場予測
・眼科用薬剤のインド市場予測
・眼科用薬剤の種類別世界市場予測(網膜障害薬、アレルギー性炎症性および感染性薬物、緑内障薬、ドライアイ治療薬、その他)
・眼科用薬剤の用途別世界市場予測(緑内障、ドライアイ症候群、網膜疾患、その他の眼科的適応症)
...

This report studies the global Pharma Ophthalmic market status and forecast, categorizes the global Pharma Ophthalmic market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).
The global Pharma Ophthalmic market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025.

The major players covered in this report
Novartis
Allergan
Roche
Valeant
Regeneron
Santen
Bayer
Pfizer
Senju
Akorn

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
United States
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Retinal disorders drugs
Allergic, inflammatory and infective drugs
Glaucoma drugs
Dry eye drugs
Other ophthalmic drugs
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Glaucoma
Dry eye syndrome
Retinal diseases
Other ophthalmic indications

The study objectives of this report are:
To analyze and study the global Pharma Ophthalmic sales, value, status (2013-2017) and forecast (2018-2025);
To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
Focuses on the key Pharma Ophthalmic players, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Pharma Ophthalmic are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Pharma Ophthalmic Manufacturers
Pharma Ophthalmic Distributors/Traders/Wholesalers
Pharma Ophthalmic Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company’s specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Pharma Ophthalmic market, by end-use.
Detailed analysis and profiles of additional market players.

【レポートの目次】

Table of Contents

Global Pharma Ophthalmic Sales Market Report 2018
1 Pharma Ophthalmic Market Overview
1.1 Product Overview and Scope of Pharma Ophthalmic
1.2 Classification of Pharma Ophthalmic by Product Category
1.2.1 Global Pharma Ophthalmic Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 Global Pharma Ophthalmic Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 Retinal disorders drugs
1.2.4 Allergic, inflammatory and infective drugs
1.2.5 Glaucoma drugs
1.2.6 Dry eye drugs
1.2.7 Other ophthalmic drugs
1.3 Global Pharma Ophthalmic Market by Application/End Users
1.3.1 Global Pharma Ophthalmic Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.1 Glaucoma
1.3.2 Dry eye syndrome
1.3.3 Retinal diseases
1.3.4 Other ophthalmic indications
1.4 Global Pharma Ophthalmic Market by Region
1.4.1 Global Pharma Ophthalmic Market Size (Value) Comparison by Region (2013-2025)
1.4.2 United States Pharma Ophthalmic Status and Prospect (2013-2025)
1.4.3 Europe Pharma Ophthalmic Status and Prospect (2013-2025)
1.4.4 China Pharma Ophthalmic Status and Prospect (2013-2025)
1.4.5 Japan Pharma Ophthalmic Status and Prospect (2013-2025)
1.4.6 Southeast Asia Pharma Ophthalmic Status and Prospect (2013-2025)
1.4.7 India Pharma Ophthalmic Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Pharma Ophthalmic (2013-2025)
1.5.1 Global Pharma Ophthalmic Sales and Growth Rate (2013-2025)
1.5.2 Global Pharma Ophthalmic Revenue and Growth Rate (2013-2025)

2 Global Pharma Ophthalmic Competition by Players/Suppliers, Type and Application
2.1 Global Pharma Ophthalmic Market Competition by Players/Suppliers
2.1.1 Global Pharma Ophthalmic Sales and Market Share of Key Players/Suppliers (2013-2018)
2.1.2 Global Pharma Ophthalmic Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Pharma Ophthalmic (Volume and Value) by Type
2.2.1 Global Pharma Ophthalmic Sales and Market Share by Type (2013-2018)
2.2.2 Global Pharma Ophthalmic Revenue and Market Share by Type (2013-2018)
2.3 Global Pharma Ophthalmic (Volume and Value) by Region
2.3.1 Global Pharma Ophthalmic Sales and Market Share by Region (2013-2018)
2.3.2 Global Pharma Ophthalmic Revenue and Market Share by Region (2013-2018)
2.4 Global Pharma Ophthalmic (Volume) by Application

3 United States Pharma Ophthalmic (Volume, Value and Sales Price)
3.1 United States Pharma Ophthalmic Sales and Value (2013-2018)
3.1.1 United States Pharma Ophthalmic Sales and Growth Rate (2013-2018)
3.1.2 United States Pharma Ophthalmic Revenue and Growth Rate (2013-2018)
3.1.3 United States Pharma Ophthalmic Sales Price Trend (2013-2018)
3.2 United States Pharma Ophthalmic Sales Volume and Market Share by Players (2013-2018)
3.3 United States Pharma Ophthalmic Sales Volume and Market Share by Type (2013-2018)
3.4 United States Pharma Ophthalmic Sales Volume and Market Share by Application (2013-2018)

4 Europe Pharma Ophthalmic (Volume, Value and Sales Price)
4.1 Europe Pharma Ophthalmic Sales and Value (2013-2018)
4.1.1 Europe Pharma Ophthalmic Sales and Growth Rate (2013-2018)
4.1.2 Europe Pharma Ophthalmic Revenue and Growth Rate (2013-2018)
4.1.3 Europe Pharma Ophthalmic Sales Price Trend (2013-2018)
4.2 Europe Pharma Ophthalmic Sales Volume and Market Share by Players (2013-2018)
4.3 Europe Pharma Ophthalmic Sales Volume and Market Share by Type (2013-2018)
4.4 Europe Pharma Ophthalmic Sales Volume and Market Share by Application (2013-2018)

5 China Pharma Ophthalmic (Volume, Value and Sales Price)
5.1 China Pharma Ophthalmic Sales and Value (2013-2018)
5.1.1 China Pharma Ophthalmic Sales and Growth Rate (2013-2018)
5.1.2 China Pharma Ophthalmic Revenue and Growth Rate (2013-2018)
5.1.3 China Pharma Ophthalmic Sales Price Trend (2013-2018)
5.2 China Pharma Ophthalmic Sales Volume and Market Share by Players (2013-2018)
5.3 China Pharma Ophthalmic Sales Volume and Market Share by Type (2013-2018)
5.4 China Pharma Ophthalmic Sales Volume and Market Share by Application (2013-2018)

6 Japan Pharma Ophthalmic (Volume, Value and Sales Price)
6.1 Japan Pharma Ophthalmic Sales and Value (2013-2018)
6.1.1 Japan Pharma Ophthalmic Sales and Growth Rate (2013-2018)
6.1.2 Japan Pharma Ophthalmic Revenue and Growth Rate (2013-2018)
6.1.3 Japan Pharma Ophthalmic Sales Price Trend (2013-2018)
6.2 Japan Pharma Ophthalmic Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Pharma Ophthalmic Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Pharma Ophthalmic Sales Volume and Market Share by Application (2013-2018)

7 Southeast Asia Pharma Ophthalmic (Volume, Value and Sales Price)
7.1 Southeast Asia Pharma Ophthalmic Sales and Value (2013-2018)
7.1.1 Southeast Asia Pharma Ophthalmic Sales and Growth Rate (2013-2018)
7.1.2 Southeast Asia Pharma Ophthalmic Revenue and Growth Rate (2013-2018)
7.1.3 Southeast Asia Pharma Ophthalmic Sales Price Trend (2013-2018)
7.2 Southeast Asia Pharma Ophthalmic Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Pharma Ophthalmic Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Pharma Ophthalmic Sales Volume and Market Share by Application (2013-2018)

8 India Pharma Ophthalmic (Volume, Value and Sales Price)
8.1 India Pharma Ophthalmic Sales and Value (2013-2018)
8.1.1 India Pharma Ophthalmic Sales and Growth Rate (2013-2018)
8.1.2 India Pharma Ophthalmic Revenue and Growth Rate (2013-2018)
8.1.3 India Pharma Ophthalmic Sales Price Trend (2013-2018)
8.2 India Pharma Ophthalmic Sales Volume and Market Share by Players (2013-2018)
8.3 India Pharma Ophthalmic Sales Volume and Market Share by Type (2013-2018)
8.4 India Pharma Ophthalmic Sales Volume and Market Share by Application (2013-2018)

9 Global Pharma Ophthalmic Players/Suppliers Profiles and Sales Data
9.1 Novartis
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Pharma Ophthalmic Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Novartis Pharma Ophthalmic Sales, Revenue, Price and Gross Margin (2013-2018)
9.1.4 Main Business/Business Overview
9.2 Allergan
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Pharma Ophthalmic Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Allergan Pharma Ophthalmic Sales, Revenue, Price and Gross Margin (2013-2018)
9.2.4 Main Business/Business Overview
9.3 Roche
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Pharma Ophthalmic Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Roche Pharma Ophthalmic Sales, Revenue, Price and Gross Margin (2013-2018)
9.3.4 Main Business/Business Overview
9.4 Valeant
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Pharma Ophthalmic Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Valeant Pharma Ophthalmic Sales, Revenue, Price and Gross Margin (2013-2018)
9.4.4 Main Business/Business Overview
9.5 Regeneron
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Pharma Ophthalmic Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Regeneron Pharma Ophthalmic Sales, Revenue, Price and Gross Margin (2013-2018)
9.5.4 Main Business/Business Overview
9.6 Santen
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Pharma Ophthalmic Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Santen Pharma Ophthalmic Sales, Revenue, Price and Gross Margin (2013-2018)
9.6.4 Main Business/Business Overview
9.7 Bayer
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Pharma Ophthalmic Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Bayer Pharma Ophthalmic Sales, Revenue, Price and Gross Margin (2013-2018)
9.7.4 Main Business/Business Overview
9.8 Pfizer
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Pharma Ophthalmic Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Pfizer Pharma Ophthalmic Sales, Revenue, Price and Gross Margin (2013-2018)
9.8.4 Main Business/Business Overview
9.9 Senju
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Pharma Ophthalmic Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Senju Pharma Ophthalmic Sales, Revenue, Price and Gross Margin (2013-2018)
9.9.4 Main Business/Business Overview
9.10 Akorn
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Pharma Ophthalmic Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Akorn Pharma Ophthalmic Sales, Revenue, Price and Gross Margin (2013-2018)
9.10.4 Main Business/Business Overview

10 Pharma Ophthalmic Maufacturing Cost Analysis
10.1 Pharma Ophthalmic Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Pharma Ophthalmic
10.3 Manufacturing Process Analysis of Pharma Ophthalmic

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Pharma Ophthalmic Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Pharma Ophthalmic Major Manufacturers in 2017
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Pharma Ophthalmic Market Forecast (2018-2025)
14.1 Global Pharma Ophthalmic Sales Volume, Revenue and Price Forecast (2018-2025)
14.1.1 Global Pharma Ophthalmic Sales Volume and Growth Rate Forecast (2018-2025)
14.1.2 Global Pharma Ophthalmic Revenue and Growth Rate Forecast (2018-2025)
14.1.3 Global Pharma Ophthalmic Price and Trend Forecast (2018-2025)
14.2 Global Pharma Ophthalmic Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
14.2.1 Global Pharma Ophthalmic Sales Volume and Growth Rate Forecast by Regions (2018-2025)
14.2.2 Global Pharma Ophthalmic Revenue and Growth Rate Forecast by Regions (2018-2025)
14.2.3 United States Pharma Ophthalmic Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.4 Europe Pharma Ophthalmic Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.5 China Pharma Ophthalmic Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.6 Japan Pharma Ophthalmic Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.7 Southeast Asia Pharma Ophthalmic Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.8 India Pharma Ophthalmic Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Pharma Ophthalmic Sales Volume, Revenue and Price Forecast by Type (2018-2025)
14.3.1 Global Pharma Ophthalmic Sales Forecast by Type (2018-2025)
14.3.2 Global Pharma Ophthalmic Revenue Forecast by Type (2018-2025)
14.3.3 Global Pharma Ophthalmic Price Forecast by Type (2018-2025)
14.4 Global Pharma Ophthalmic Sales Volume Forecast by Application (2018-2025)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Pharma Ophthalmic
Figure Global Pharma Ophthalmic Sales Volume Comparison (K Pcs) by Type (2013-2025)
Figure Global Pharma Ophthalmic Sales Volume Market Share by Type (Product Category) in 2017
Figure Retinal disorders drugs Product Picture
Figure Allergic, inflammatory and infective drugs Product Picture
Figure Glaucoma drugs Product Picture
Figure Dry eye drugs Product Picture
Figure Other ophthalmic drugs Product Picture
Figure Global Pharma Ophthalmic Sales Comparison (K Pcs) by Application (2013-2025)
Figure Global Sales Market Share of Pharma Ophthalmic by Application in 2017
Figure Glaucoma Examples
Table Key Downstream Customer in Glaucoma
Figure Dry eye syndrome Examples
Table Key Downstream Customer in Dry eye syndrome
Figure Retinal diseases Examples
Table Key Downstream Customer in Retinal diseases
Figure Other ophthalmic indications Examples
Table Key Downstream Customer in Other ophthalmic indications
Figure Global Pharma Ophthalmic Market Size (Million USD) by Regions (2013-2025)
Figure United States Pharma Ophthalmic Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Pharma Ophthalmic Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Pharma Ophthalmic Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Pharma Ophthalmic Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Pharma Ophthalmic Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Pharma Ophthalmic Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Pharma Ophthalmic Sales Volume (K Pcs) and Growth Rate (2013-2025)
Figure Global Pharma Ophthalmic Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Market Major Players Pharma Ophthalmic Sales Volume (K Pcs) (2013-2018)
Table Global Pharma Ophthalmic Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table Global Pharma Ophthalmic Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Pharma Ophthalmic Sales Share by Players/Suppliers
Figure 2017 Pharma Ophthalmic Sales Share by Players/Suppliers
Figure Global Pharma Ophthalmic Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Pharma Ophthalmic Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Pharma Ophthalmic Revenue Share by Players/Suppliers (2013-2018)
Table 2017 Global Pharma Ophthalmic Revenue Share by Players
Table 2017 Global Pharma Ophthalmic Revenue Share by Players
Table Global Pharma Ophthalmic Sales (K Pcs) and Market Share by Type (2013-2018)
Table Global Pharma Ophthalmic Sales Share (K Pcs) by Type (2013-2018)
Figure Sales Market Share of Pharma Ophthalmic by Type (2013-2018)
Figure Global Pharma Ophthalmic Sales Growth Rate by Type (2013-2018)
Table Global Pharma Ophthalmic Revenue (Million USD) and Market Share by Type (2013-2018)
Table Global Pharma Ophthalmic Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Pharma Ophthalmic by Type (2013-2018)
Figure Global Pharma Ophthalmic Revenue Growth Rate by Type (2013-2018)
Table Global Pharma Ophthalmic Sales Volume (K Pcs) and Market Share by Region (2013-2018)
Table Global Pharma Ophthalmic Sales Share by Region (2013-2018)
Figure Sales Market Share of Pharma Ophthalmic by Region (2013-2018)
Figure Global Pharma Ophthalmic Sales Growth Rate by Region in 2017
Table Global Pharma Ophthalmic Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Pharma Ophthalmic Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Pharma Ophthalmic by Region (2013-2018)
Figure Global Pharma Ophthalmic Revenue Growth Rate by Region in 2017
Table Global Pharma Ophthalmic Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Pharma Ophthalmic Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Pharma Ophthalmic by Region (2013-2018)
Figure Global Pharma Ophthalmic Revenue Market Share by Region in 2017
Table Global Pharma Ophthalmic Sales Volume (K Pcs) and Market Share by Application (2013-2018)
Table Global Pharma Ophthalmic Sales Share (%) by Application (2013-2018)
Figure Sales Market Share of Pharma Ophthalmic by Application (2013-2018)
Figure Global Pharma Ophthalmic Sales Market Share by Application (2013-2018)
Figure United States Pharma Ophthalmic Sales (K Pcs) and Growth Rate (2013-2018)
Figure United States Pharma Ophthalmic Revenue (Million USD) and Growth Rate (2013-2018)
Figure United States Pharma Ophthalmic Sales Price (USD/Pcs) Trend (2013-2018)
Table United States Pharma Ophthalmic Sales Volume (K Pcs) by Players (2013-2018)
Table United States Pharma Ophthalmic Sales Volume Market Share by Players (2013-2018)
Figure United States Pharma Ophthalmic Sales Volume Market Share by Players in 2017
Table United States Pharma Ophthalmic Sales Volume (K Pcs) by Type (2013-2018)
Table United States Pharma Ophthalmic Sales Volume Market Share by Type (2013-2018)
Figure United States Pharma Ophthalmic Sales Volume Market Share by Type in 2017
Table United States Pharma Ophthalmic Sales Volume (K Pcs) by Application (2013-2018)
Table United States Pharma Ophthalmic Sales Volume Market Share by Application (2013-2018)
Figure United States Pharma Ophthalmic Sales Volume Market Share by Application in 2017
Figure Europe Pharma Ophthalmic Sales (K Pcs) and Growth Rate (2013-2018)
Figure Europe Pharma Ophthalmic Revenue (Million USD) and Growth Rate (2013-2018)
Figure Europe Pharma Ophthalmic Sales Price (USD/Pcs) Trend (2013-2018)
Table Europe Pharma Ophthalmic Sales Volume (K Pcs) by Players (2013-2018)
Table Europe Pharma Ophthalmic Sales Volume Market Share by Players (2013-2018)
Figure Europe Pharma Ophthalmic Sales Volume Market Share by Players in 2017
Table Europe Pharma Ophthalmic Sales Volume (K Pcs) by Type (2013-2018)
Table Europe Pharma Ophthalmic Sales Volume Market Share by Type (2013-2018)
Figure Europe Pharma Ophthalmic Sales Volume Market Share by Type in 2017
Table Europe Pharma Ophthalmic Sales Volume (K Pcs) by Application (2013-2018)
Table Europe Pharma Ophthalmic Sales Volume Market Share by Application (2013-2018)
Figure Europe Pharma Ophthalmic Sales Volume Market Share by Application in 2017
Figure China Pharma Ophthalmic Sales (K Pcs) and Growth Rate (2013-2018)
Figure China Pharma Ophthalmic Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Pharma Ophthalmic Sales Price (USD/Pcs) Trend (2013-2018)
Table China Pharma Ophthalmic Sales Volume (K Pcs) by Players (2013-2018)
Table China Pharma Ophthalmic Sales Volume Market Share by Players (2013-2018)
Figure China Pharma Ophthalmic Sales Volume Market Share by Players in 2017
Table China Pharma Ophthalmic Sales Volume (K Pcs) by Type (2013-2018)
Table China Pharma Ophthalmic Sales Volume Market Share by Type (2013-2018)
Figure China Pharma Ophthalmic Sales Volume Market Share by Type in 2017
Table China Pharma Ophthalmic Sales Volume (K Pcs) by Application (2013-2018)
Table China Pharma Ophthalmic Sales Volume Market Share by Application (2013-2018)
Figure China Pharma Ophthalmic Sales Volume Market Share by Application in 2017
Figure Japan Pharma Ophthalmic Sales (K Pcs) and Growth Rate (2013-2018)
Figure Japan Pharma Ophthalmic Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Pharma Ophthalmic Sales Price (USD/Pcs) Trend (2013-2018)
Table Japan Pharma Ophthalmic Sales Volume (K Pcs) by Players (2013-2018)
Table Japan Pharma Ophthalmic Sales Volume Market Share by Players (2013-2018)
Figure Japan Pharma Ophthalmic Sales Volume Market Share by Players in 2017
Table Japan Pharma Ophthalmic Sales Volume (K Pcs) by Type (2013-2018)
Table Japan Pharma Ophthalmic Sales Volume Market Share by Type (2013-2018)
Figure Japan Pharma Ophthalmic Sales Volume Market Share by Type in 2017
Table Japan Pharma Ophthalmic Sales Volume (K Pcs) by Application (2013-2018)
Table Japan Pharma Ophthalmic Sales Volume Market Share by Application (2013-2018)
Figure Japan Pharma Ophthalmic Sales Volume Market Share by Application in 2017
Figure Southeast Asia Pharma Ophthalmic Sales (K Pcs) and Growth Rate (2013-2018)
Figure Southeast Asia Pharma Ophthalmic Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Pharma Ophthalmic Sales Price (USD/Pcs) Trend (2013-2018)
Table Southeast Asia Pharma Ophthalmic Sales Volume (K Pcs) by Players (2013-2018)
Table Southeast Asia Pharma Ophthalmic Sales Volume Market Share by Players (2013-2018)
Figure Southeast Asia Pharma Ophthalmic Sales Volume Market Share by Players in 2017
Table Southeast Asia Pharma Ophthalmic Sales Volume (K Pcs) by Type (2013-2018)
Table Southeast Asia Pharma Ophthalmic Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Pharma Ophthalmic Sales Volume Market Share by Type in 2017
Table Southeast Asia Pharma Ophthalmic Sales Volume (K Pcs) by Application (2013-2018)
Table Southeast Asia Pharma Ophthalmic Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Pharma Ophthalmic Sales Volume Market Share by Application in 2017
Figure India Pharma Ophthalmic Sales (K Pcs) and Growth Rate (2013-2018)
Figure India Pharma Ophthalmic Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Pharma Ophthalmic Sales Price (USD/Pcs) Trend (2013-2018)
Table India Pharma Ophthalmic Sales Volume (K Pcs) by Players (2013-2018)
Table India Pharma Ophthalmic Sales Volume Market Share by Players (2013-2018)
Figure India Pharma Ophthalmic Sales Volume Market Share by Players in 2017
Table India Pharma Ophthalmic Sales Volume (K Pcs) by Type (2013-2018)
Table India Pharma Ophthalmic Sales Volume Market Share by Type (2013-2018)
Figure India Pharma Ophthalmic Sales Volume Market Share by Type in 2017
Table India Pharma Ophthalmic Sales Volume (K Pcs) by Application (2013-2018)
Table India Pharma Ophthalmic Sales Volume Market Share by Application (2013-2018)
Figure India Pharma Ophthalmic Sales Volume Market Share by Application in 2017
Table Novartis Basic Information List
Table Novartis Pharma Ophthalmic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Novartis Pharma Ophthalmic Sales Growth Rate (2013-2018)
Figure Novartis Pharma Ophthalmic Sales Global Market Share (2013-2018)
Figure Novartis Pharma Ophthalmic Revenue Global Market Share (2013-2018)
Table Allergan Basic Information List
Table Allergan Pharma Ophthalmic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Allergan Pharma Ophthalmic Sales Growth Rate (2013-2018)
Figure Allergan Pharma Ophthalmic Sales Global Market Share (2013-2018)
Figure Allergan Pharma Ophthalmic Revenue Global Market Share (2013-2018)
Table Roche Basic Information List
Table Roche Pharma Ophthalmic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Roche Pharma Ophthalmic Sales Growth Rate (2013-2018)
Figure Roche Pharma Ophthalmic Sales Global Market Share (2013-2018
Figure Roche Pharma Ophthalmic Revenue Global Market Share (2013-2018)
Table Valeant Basic Information List
Table Valeant Pharma Ophthalmic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Valeant Pharma Ophthalmic Sales Growth Rate (2013-2018)
Figure Valeant Pharma Ophthalmic Sales Global Market Share (2013-2018)
Figure Valeant Pharma Ophthalmic Revenue Global Market Share (2013-2018)
Table Regeneron Basic Information List
Table Regeneron Pharma Ophthalmic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Regeneron Pharma Ophthalmic Sales Growth Rate (2013-2018)
Figure Regeneron Pharma Ophthalmic Sales Global Market Share (2013-2018)
Figure Regeneron Pharma Ophthalmic Revenue Global Market Share (2013-2018)
Table Santen Basic Information List
Table Santen Pharma Ophthalmic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Santen Pharma Ophthalmic Sales Growth Rate (2013-2018)
Figure Santen Pharma Ophthalmic Sales Global Market Share (2013-2018
Figure Santen Pharma Ophthalmic Revenue Global Market Share (2013-2018)
Table Bayer Basic Information List
Table Bayer Pharma Ophthalmic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Bayer Pharma Ophthalmic Sales Growth Rate (2013-2018)
Figure Bayer Pharma Ophthalmic Sales Global Market Share (2013-2018)
Figure Bayer Pharma Ophthalmic Revenue Global Market Share (2013-2018)
Table Pfizer Basic Information List
Table Pfizer Pharma Ophthalmic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Pfizer Pharma Ophthalmic Sales Growth Rate (2013-2018)
Figure Pfizer Pharma Ophthalmic Sales Global Market Share (2013-2018
Figure Pfizer Pharma Ophthalmic Revenue Global Market Share (2013-2018)
Table Senju Basic Information List
Table Senju Pharma Ophthalmic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Senju Pharma Ophthalmic Sales Growth Rate (2013-2018)
Figure Senju Pharma Ophthalmic Sales Global Market Share (2013-2018)
Figure Senju Pharma Ophthalmic Revenue Global Market Share (2013-2018)
Table Akorn Basic Information List
Table Akorn Pharma Ophthalmic Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Akorn Pharma Ophthalmic Sales Growth Rate (2013-2018)
Figure Akorn Pharma Ophthalmic Sales Global Market Share (2013-2018)
Figure Akorn Pharma Ophthalmic Revenue Global Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Pharma Ophthalmic
Figure Manufacturing Process Analysis of Pharma Ophthalmic
Figure Pharma Ophthalmic Industrial Chain Analysis
Table Raw Materials Sources of Pharma Ophthalmic Major Players in 2017
Table Major Buyers of Pharma Ophthalmic
Table Distributors/Traders List
Figure Global Pharma Ophthalmic Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Global Pharma Ophthalmic Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Pharma Ophthalmic Price (USD/Pcs) and Trend Forecast (2018-2025)
Table Global Pharma Ophthalmic Sales Volume (K Pcs) Forecast by Regions (2018-2025)
Figure Global Pharma Ophthalmic Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Pharma Ophthalmic Sales Volume Market Share Forecast by Regions in 2025
Table Global Pharma Ophthalmic Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Pharma Ophthalmic Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Pharma Ophthalmic Revenue Market Share Forecast by Regions in 2025
Figure United States Pharma Ophthalmic Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure United States Pharma Ophthalmic Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Europe Pharma Ophthalmic Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Europe Pharma Ophthalmic Revenue and Growth Rate Forecast (2018-2025)
Figure China Pharma Ophthalmic Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure China Pharma Ophthalmic Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Pharma Ophthalmic Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Japan Pharma Ophthalmic Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Pharma Ophthalmic Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Pharma Ophthalmic Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Pharma Ophthalmic Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure India Pharma Ophthalmic Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Pharma Ophthalmic Sales (K Pcs) Forecast by Type (2018-2025)
Figure Global Pharma Ophthalmic Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Pharma Ophthalmic Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Pharma Ophthalmic Revenue Market Share Forecast by Type (2018-2025)
Table Global Pharma Ophthalmic Price (USD/Pcs) Forecast by Type (2018-2025)
Table Global Pharma Ophthalmic Sales (K Pcs) Forecast by Application (2018-2025)
Figure Global Pharma Ophthalmic Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【レポートのキーワード】

眼科用薬剤、網膜障害薬、アレルギー性炎症性および感染性薬物、緑内障薬、ドライアイ治療薬、緑内障、ドライアイ症候群、網膜疾患の眼科的適応症

【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[眼科用薬剤の世界市場:販売動向2018] (Global Pharma Ophthalmic Sales Market Report 2018 / QYR80710157)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆